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Anthraquinones isolated from the ethanol extract of the roots of K. valerianoides 2611. Introduction
Knoxia valerianoides Thorel ex Pitard is one of the only two
Knoxia species (Rubiaceae) distributed in the Chinese mainland.
The dried roots are commonly used as purgative and anti-ulcer
medicine. Chemical and pharmacological investigation indicated
that it mainly contained 9,10-anthraquinones, with inhibitory
activities against the formation of advanced glycation end
products and rat lens aldose reductase1–5. As part of a programme
to assess the chemical and biological diversities of traditional
Chinese medicines6–10, we investigated an ethanol extract of the
roots of K. valerianoides. In our previous study, ﬁve new 9,10-
anthraquinones including a dihydrofurano-9,10-anthraquinone11,
together with 21 known analogues12, were isolated from an
ethanol extract of the roots of K. valerianoides. Continuing
examination of the same extract led to the characterisation of
eight new anthraquinones including three acetonide derivatives of
3-hydroxy-2-hydroxymethyl-9,10-anthraquinones (1–8). Although
several 2-methoxymethyl- and 2-ethoxymethyl-9,10-anthraqui-
nones (9–13) were previously reported as natural products from
this plant1,3,11,12, chemical transformation of the co-occurring 14
and 15 and HPLC–ESI–MS analysis of the plant extracts showed
that the reported1,3,11,12 and isolated analogues (4–13) were
solvolytic artifacts formed in the extraction and isolation. In
addition, it was found that the acetonide (S16) of 3-hydroxy-2-
hydroxymethyl-1-methoxy-9,10-anthraquinone (16) was decom-
posed by oxidation into two major products, damnacanthal
(S16a) and 2-carboxyl-3-hydroxy-1-methoxy-9,10-anthraquinone
acetonide (S16b) (Fig. 1).O
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16 R1 = OMe, R2 = CH2OH, R3 = R4 = H
17 R1 = OH, R2 = OMe, R3 = R4 = H
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O
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Figure 1 Structures of compounds 1–17, S16, S16a, and S16b.2. Results and discussion
Compound 1, an orange amorphous solid, showed IR absorptions
for hydroxy (3523 and 3457 cm1), conjugated carbonyl
(1675 cm1), and aromatic ring (1626, 1592 cm1) functional
groups. The molecular formula of 1 (C15H10O5) was indicated
by ()–HR–ESI–MS at m/z 269.0451 [M–H] (calcd. for
C15H9O5, 269.0455) combined with the NMR data (Tables 1
and 2). The 1H NMR spectrum of 1 showed resonances attributed
to a pair of meta-coupled aromatic protons at d 6.65 (d, J¼2.5
Hz, H-2) and 7.24 (d, J¼2.5 Hz, H-4), a set of ortho-meta-coupled
ABX aromatic protons at d 7.63 (d, J¼2.5 Hz, H-5), 7.40
(dd, J¼8.5 and 2.5 Hz, H-7), and 8.21 (d, J¼8.5 Hz, H-8), an
aromatic methoxy group at d 4.02 (s, OMe-6), a hydrogen bonded
phenolic hydroxy proton at d 12.95 (s, OH-1), and a broadened
phenolic hydroxy proton at d 9.92 (brs, OH-3). This indicated the
presence of two aromatic rings in 1, having tetra- and tri-
substituted patterns, respectively. The 13C NMR spectrum of 1
showed a sp3 resonance of the methoxy group and 14 sp2 carbon
resonances including two typical carbonyls at d 186.9 (C-9) and
182.7 (C-10) (Table 2) for the 9,10-anthraquinone nucleus11–16.
These spectroscopic data revealed that compound 1 was a
dihydroxy-methoxy-substituted 9,10-anthraquinone analogue.
In the HMBC spectrum of 1, two- and three-bond correlations
of OH-1/C-1, C-2, and C-9a and H-2/C-9a, C-3, and C-4, together
with the shifts of these proton and carbon resonances located
unambiguously the hydrogen bonded hydroxy group at C-1. In
addition, HMBC correlations of H-4/C-2, C-3, C-9a, C-10, and
C-10a; H-5/C-7, C-8a, C-10, and C-10a; H-8/C-6, C-9, and C-10a;
and OMe/C-6 located the remained hydroxy and methoxy groups
at C-3 and C-6, respectively. Therefore, compound 1 was
determined as 1,3-dihydroxy-6-methoxy-9,10-anthraquinone.
The spectroscopic data of compound 2 (Tables 1 and 2 and
Section 3) indicated that it was an isomer of 1 with the
methoxy group located at C-1, which was supported by the
absence of the hydrogen bonded phenolic hydroxy proton in
the 1H NMR spectrum of 2. This was further conﬁrmed by
correlations from the methoxy protons to C-1, from H-2 to
C-1, C-3, and C-9a, and from H-4 to C-2, C-3, C-9a, and C-10
in the gHMBC spectrum of 2. Thus, compound 2 was assigned
as 3,6-dihydroxy-1-methoxy-9,10-anthraquinone.
Compound 3 had molecular formula C15H10O6 as indicated by
()–HR–ESI–MS at m/z 285.0407 [M–H] (calcd. for C15H10O6,
285.0405) and NMR data (Tables 1 and 2). The NMR data of 3
indicated that it was a trihydroxy-9,10-anthraquinone analogue
with a hydroxymethyl substituent and two pairs of aromatic
protons respectively possessing ortho- and para-positions. In the
gHMBC spectrum of 3, correlations from H2-11 to C-1, C-2, and
C-3, from both H-1 and H-8 to C-9, and from H-4 to C-2, C-3, C-
10, together with their shifts, revealed that the hydroxymethyl and
three hydroxy groups were located at C-2, C-3, C-5, and C-6,
respectively. Accordingly, compound 3 was deﬁned as 3,5,6-
trihydroxy-2-hydroxymethyl-9,10-anthraquinone.
The spectroscopic data of compound 4 (C17H14O7) (Tables 1
and 2 and Section 3) indicated that it was an analogue of 3 with
an O-ethyl group at C-11 and an additional hydrogen-bonded
hydroxy group substituted at C-1 or C-4. The gHMBC spectrum
of 4 showed correlations of OH-1/C-1, C-2, and C-9a; H-4/C-10,
H-8/C-9; and H2-11/C-1, C-2, C-3, and OCH2CH3. This veriﬁed
the presence and location of the 1-hydroxy and 11-ethoxy groups
in 4. Thus, compound 4 was deﬁned as 1,3,5,6-tetrahydroxy-2-
ethoxymethyl-9,10-anthraquinone.
Table 1 1H NMR spectroscopic data of compounds 1–8a.
Position Compounds (d)
1 2 3 4b 5 6c 7c 8c
1 8.20 s
2 6.65 d (2.5) 6.75 d (2.4)
4 7.24 d (2.5) 7.21 d (2.4) 7.55 s 7.27 s 7.32 s 7.08 s 7.30 s 7.29 s
5 7.63 d (2.5) 7.40 d (2.4) 7.56 d (1.5) 8.26 dd (8.5, 2.5)
6 7.77 ddd (8.5, 8.5,
2.5)
7 7.40 dd
(8.5, 2.5)
7.10 dd
(8.4, 2.4)
7.18 d
(8.5)
7.19 d
(8.5)
7.15 d
(8.5)
7.26 dd
(1.5, 8.5)
7.16 d
(8.5)
7.78 ddd (8.5, 8.5,
2.5)
8 8.21 d (8.5) 8.02 d (8.4) 7.60 d
(8.5)
7.64 d
(8.5)
7.83 d
(8.5)
8.12 d (8.5) 7.84 d
(8.5)
8.28 dd (8.5, 2.5)
11 4.57 s 4.45 s 4.93 s 4.87 s 4.91 s 4.92 s
1-OH/OMe 12.95 s/ /3.88 s 13.56 s/ 13.51 s/ 13.32 brs/ 13.31 s/ 13.09 s/
11-OMe 3.57 s
3-OH 9.92 brs 11.05 s 10.94 brs 9.37 brs
5-OH 12.61 s 12.55 brs 13.03 s 13.05 s
6-OH 10.68 s 11.36 brs
6-OMe 4.02 4.02 s 4.02 s
aData were measured at 500 MHz in acetone-d6 for 1 and 6; in DMSO-d6 for 3 and 4; and in CDCl3 for 5, 7, and 8; at 600 MHz in
MeOH-d4 for 2. The assignments were based on HMBC experiments.
bData for OEt of 4: d 3.47 (q, J¼7.0 Hz) and 1.08 (t, J¼7.0 Hz).
cData for acetonide unit of 6–8: d 1.58 (s), 1.60 (s), and 1.60 (s).
Table 2 13C NMR data of compounds 1–8a.
Position Compounds(d)
1 2 3 4b 5 6c 7c 8c
1 166.3 164.6 126.0 163.6 162.0 158.4 160.5 160.3
2 108.8 105.8 136.9 117.7 115.1 114.1 114.0 113.1
3 165.4 165.8 159.0 163.4 163.6 157.8 157.9 158.3
4 108.9 108.2 110.8 107.2 109.4 109.1 109.4 109.7
4a 136.4 138.9 133.0 133.7 133.9 134.5 133.2 133.6
5 111.4 112.6 150.6 151.2 153.2 114.0 153.2 127.3
6 165.5 163.7 152.0 152.9 154.1 165.7 154.1 134.1
7 121.3 122.5 120.6 120.7 115.6 122.4 115.6 134.1
8 130.0 130.7 120.5 121.0 120.6 130.4 120.6 126.7
8a 127.4 128.8 124.0 123.4 125.1 125.7 125.0 133.5
9 186.9 182.3 179.9 185.0 185.6 187.6 185.8 187.1
9a 110.7 114.9 125.5 109.0 109.7 110.2 109.7 113.1
10 182.7 184.8 188.9 187.9 188.2 182.4 188.2 182.1
10a 136.5 135.9 116.3 116.0 116.0 136.7 116.0 133.4
11 57.8 59.2 69.0 58.0 57.7 57.6
1-OMe 56.6
11-OMe 59.4
6-OMe 56.5 56.4 56.4
aData were measured at 125 MHz in acetone-d6 for 1 and 6; in DMSO-d6 for 3 and 4; in MeOH-d4 for 2; and in CDCl3 for 5, 7, and 8.
The assignments were based on HMBC experiments.
bData for OEt of 4: d 67.0 and 15.4; and 65.1 and 15.1.
cData for acetonide of 6–8: d 24.8 and 102.0; 24.7 and 101.3; 24.7 and 101.3.
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Section 3) showed that it was an analogue of 4 with two
methoxy groups respectively substituting the ethoxy and one
hydroxy group. In the gHMBC spectrum of 5, protons of the
two methoxy groups correlated, respectively, with C-6 and C-11.Accordingly, compound 5 was determined as 1,3,5-trihydroxy-6-
methoxy-2-methoxymethyl-9,10-anthraquinone.
The spectroscopic data of compound 6 (Tables 1 and 2
and Section 3), C18H14O6 [()–HR–ESI–MS], resembled
those of the co-occurring 1,3,6-trihydroxy-2-ethoxymethyl-9,
Anthraquinones isolated from the ethanol extract of the roots of K. valerianoides 26310-anthraquinone11, except that NMR resonances of the O-
ethyl group in 1,3,6-trihydroxy-2-ethoxymethyl-9,10-anthra-
quinone were replaced by those of an isopropylidene group. In
addition, C-1, C-2, C-3, and C-11 in 6 were shielded as compared
to 1,3,6-trihydroxy-2-ethoxymethyl-9,10-anthraquinone, suggest-
ing that 6 was the 3-hydroxy-2-hydroxymethyl-acetonide analogue
of 1,3,6-trihydroxy-2-ethoxymethyl-9,10-anthraquinone. The sug-
gestion was supported by HMBC correlations from H-11, H3-1
0,
and H3-3
0 to C-20, and by the molecular formula combined with
the shift of C-9 (dC 187.6) in 6 since C-9 resonated at dCo185 in
the 9,10-anthraquinones without the hydrogen-bonded OH-1
(compounds 1–5). Therefore, compound 6 was identiﬁed as
1,3,6-trihydroxy-2-hydroxymethyl-9,10-anthraquinone-3-hydroxy-
2-hydroxymethyl-acetonide.
Compound 7, C19H16O7 (HR–ESI–MS), showed spectro-
scopic data (Tables 1 and 2 and Section 3) similar to those of
6. Comparison of the NMR data of 7 and 6 indicated that the
resonances of H-5 and OH-6 in 6 were replaced respectively by
those of a hydrogen bonded OH and an OMe group in 7.
In addition, H-4 and C-5 and C-10 in 7 were deshielded, as
compared to 6, whereas H-7 and H-8 and C-6, C-7, C-8, and
C-10a were shielded. This suggested that 7 was an analogue of
6 with the hydroxy and methoxy groups substituted at C-5 and
C-6, respectively. The suggestion was conﬁrmed by correla-
tions of H2-11/C-1, C-2, C-3, and C-1
0, OH-1/C-1, C-2, and
C-9a, OH-5/C-5, C-6, and C-10a, and OMe-6/C-6 in the
gHMBC spectrum. Thus, compound 7 was deﬁned as 1,3,5-
trihydroxy-2-hydroxymethyl-6-methoxy-9,10-anthraquinone-
3-hydroxy-2-hydroxymethyl-acetonide.
Compound 8 was the 6-deoxy analogue of 6 as indicated by
its spectroscopic data (Tables 1 and 2 and Section 3) and
conﬁrmed by an enhancement of OH-1 upon irradiation of H2-
11 and enhancements of H-4 and H2-11 by irradiation of H3-1
0
and H3-3
0 in the NOE difference spectrum. Therefore, com-
pound 8 was identiﬁed as 1,3-dihydroxy-2-hydroxymethyl-9,10-
anthraquinone-3-hydroxy-2-hydroxymethyl-acetonide.
Since the anthraquinones containing methoxy, ethoxy, and
isopropylidene units, such as compounds 4–8, as well as the
reported analogues 9–131,3,11,12, might be solvolytic artifacts
produced in the extraction and isolation procedure, chemical
transformation of the co-occurring 14 and 1512 and HPLC–UV–
ESI–MS analysis of extracts obtained with a different solvent
extraction procedure were carried out. When ethanol or methanol
solutions of 14 or 15 were separately stirred at room temperature
for 24 h, no product was generated in the solutions as indicated
by TLC. However, after the solutions were reﬂuxed for another
12 h, compounds 9 and 10 were obtained in the ethanol solutions,
respectively, and compounds 11 and 12 were isolated in the
methanol solutions. This demonstrated that the hydroxy group of
2-hydroxymethyl-9,10-anthraquinones was readily etheriﬁed with
the solvents, indicating that compounds 4, 5, and the reported
analogues (9–13)1,3,11,12 were solvolytic artifacts. This was further
conﬁrmed by HPLC–UV–ESI–MS analysis of the extracts. A
comparison of those peaks in the chromatograms of the extracts
obtained by ultrasonicating the plant material with the solvents
for half an hour, to the chromatograms of the extracts prepared
by reﬂuxing the plant material with ethanol or methanol for 2 h,
indicated the relative intensities for the peaks of 2-hydroxymethy-
lanthraquinones (14–16) were signiﬁcantly decreased, whereas,
the relative intensities of peaks for 2-ethoxymethyl-(4, 9, 10, and
13) or 2-methoxymethyl-9,10-anthraquinones (5, 11, and 12) were
signiﬁcantly increased. Comparison of the chromatograms of theextracts obtained by separately reﬂuxing or ultrasonicating the
plant material with acetone indicated that the relative intensities
of the peaks for the major components were not changed
signiﬁcantly. In addition, although compounds 6–8 were not
distinguished from the extracts by HPLC–UV–ESI–MS analysis,
compounds 8 and S16 were obtained in low yields, respectively
from the acetone suspensions of 14 and 16 after the suspensions
were separately reﬂuxed for 24 h. This suggested that the
acetonides of 3-hydroxy-2-hydroxymethyl-9,10-anthraquinones
could be formed in the isolation procedures, but the yield was
limited due to low solubility of the precursors. The low yields
were consistent with the minor amounts of 6–8 obtained in the
isolation. Though the mutual conversion of 16 and S16 was
reported17, in this study, it was found that S16 was instable in
solutions at ambient conditions. Further investigation indicated
that S16 was decomposed by oxidation into two major products
S16a and S16b with different reaction rates and products ratios in
CHCl3 (faster; S16a/S16b, about 3:2) and acetone (slower; S16a/
S16b, about 1:5).
In the in vitro bioassays, at 10 mM, compound 4 protected
hepatocytes (WB-F344 cells) damage induced by DL-galacto-
samine (GalN) with a 28.073.2% inhibition (the positive
control bicyclol showed a 27.072.8% inhibition)18.3. Experimental
3.1. Equipment and reagents
IR spectra were recorded as KBr pellets on a Nicolet 5700 FT-
IR spectrophotometer. UV spectra were measured on a Cary
300 spectrophotometer. NMR spectra were obtained at 500 or
600 MHz for 1H, and 125 MHz for 13C on Inova 500 and
600 MHz spectrometers in DMSO-d6, CD3OD, Me2CO-d6 or
CDCl3 with solvent peaks being used as references. ESI-MS
and HPLC–UV–ESI–MS data were measured with a Q-Trap
LC/MS/MS (Turbo Ionspray source) spectrometer. HR–ESI–
MS data were respectively measured using a Micromass
Autospec-Ultima ETOF and an AccuToFCS JMS-T100CS
spectrometers. Column chromatography was performed with
silica gel (100–200 or 200–300 mesh, Qingdao Marine Chemi-
cal Inc. China) and Sephadex LH-20 (Pharmacia Biotech AB,
Uppsala Sweden). HPLC separation was performed on an
instrument consisting of a Waters 600 controller, a Waters 600
pump, and a Waters 2487 dual l absorbance detector with an
Alltima (250 mm 10 mm i.d.) column packed with C18
(5 mm). TLC was carried out with glass precoated silica gel
GF254 plates (Yantai Jiangyou Silica Gel Technology Devel-
opment Co. Ltd., China). Spots were visualised under UV
light or by spraying with 10% H2SO4 in 95% EtOH followed
by heating.3.2. Plant materials
Roots of K. valerianoides were purchased at Anguo medicinal
herb market of Hebei province, which were collected in Dali,
Yunnan province, in 2006. Plant identiﬁcation was veriﬁed by
Associate Prof. Lin Ma (Institute of Materia Medica). A
voucher specimen (No. HDJ070413) is deposited at the
Herbarium of the Department of Medicinal Plants, Institute
of Materia Medica, Beijing, China.
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The dried roots of K. valerianoides (20 kg) were powdered and
extracted with 10.0 L of 95% EtOH at room temperature for
3 48 h. The EtOH extract was evaporated under reduced
pressure to yield a dark brown residue (3.9 kg). The residue
was suspended in H2O (3000 mL) and then partitioned with
EtOAc (3000 mL 3). The EtOAc layer (400 g) was chroma-
tographed over silica gel with a gradient of increasing acetone
in petroleum ether (100:0–0:100) to afford nine fractions
(Fr.1–Fr.9) based on thin layer chromatographic (TLC) test.
Fr.3 (10 g) was chromatographed over silica gel, with a
gradient of increasing ethyl acetate in petroleum ether (0–
100%), to yield Fr.3-1–Fr.3-23, of which Fr.3-1 (30 mg) was
subjected to CC over Sephadex LH-20 [petroleum ether-
CHCl3-CH3OH (5:5:1)] to afford 8 (5.8 mg). Fr.4 (15 g) was
chromatographed over silica gel with a gradient of increasing
ethyl acetate in petroleum ether (5–100%) to afford Fr.4-1–
Fr.4-46, and Fr.4-4 (0.12 g) was further subjected to CC over
Sephadex LH-20 [petroleum ether –CHCl3–CH3OH (5:5:1)] to
give 18 subfractions. Fr.4-4-13 (15 mg) was puriﬁed by pre-
parative TLC developing with petroleum etherethyl acetate
(10:1) to give 7 (3.1 mg). Puriﬁcation of Fr.4-14-8 (27 mg) by
preparative TLC [petroleum etheracetone (10:1.5)] afforded
5 (4.5 mg). Separation of Fr.4-14-16 (71 mg) by preparative
TLC [petroleum etheracetone (5:1)] afforded 1 (6.1 mg).
Fr.4-20 (0.44 g) was separated into 12 subfractions by CC
over Sephadex LH-20 [petroleum ether–CHCl3–CH3OH
(5:5:1)], of which Fr.4-20-5 (7 mg) was separated by reversed-
phase semipreparative HPLC [CH3OH–H2O (81:19)] to yield 6
(1.8 mg). Fr.5 (24 g) was chromatographed over silica gel with a
gradient of increasing acetone in petroleum ether (10–100%), to
yield 60 subfractions, of which Fr.5-21–Fr.5-43 (10 g) were
combined and separated by reversed-phase MPLC with a
gradient of increasing CH3OH (50–100%) in H2O to afford
seven subfractions. Fr.5-21-7 (1.2 g) was chromatographed over
Sephadex LH-20 [CHCl3–CH3OH (1:1)] to yield 4 (5.3 mg).
Fr.6 (30 g) was subjected to CC over silica gel with a gradient of
increasing CH3OH in CHCl3 (1–100%) to afford Fr.6-1–Fr.6-
101. Fr.6-54 (0.53 g) was separated by CC over Sephadex LH-
20 [CHCl3–CH3OH (1:1)] to afford 14 subfractions, of which
Fr.6-54-3 (17 mg) was puriﬁed by reversed-phase semiprepara-
tive HPLC [CH3OH–H2O (64:36)] to yield 2 (6.7 mg). Fr.6-60
(0.46 g) was chromatographed over Sephadex LH-20 [CHCl3–
CH3OH (1:1)] to afford nine subfractions, of which Fr.6-60-9
(39 mg) was separated by reversed-phase semipreparative
HPLC [CH3OH–H2O (58:42)] to obtain 3 (9.2 mg).3.4. Identiﬁcation
1,3-Dihydroxy-6-methoxy-9,10-anthraquinone (1): orange
amorphous solid; UV (MeOH) lmax nm (log e) 202 (sh,
4.14), 214 (4.33), 274 (4.44), 336 (2.97), 424 (3.14); IR (KBr)
nmax cm
1 3523, 3457, 3078, 2968, 1675, 1626, 1592, 1494,
1439, 1382, 1301, 1274, 1226, 1189, 1153, 1108, 1052, 1022,
1010, 935, 902, 834, 786, 749, 722, 665, 603; 1H NMR
(acetone-d6, 500 MHz) data, see Table 1;
13C NMR (acet-
one-d6, 125 MHz) data, see Table 2; ()–ESI-MS m/z 269 [M–
H]; ()–HR–ESI–MS m/z 269.0451 [M–H] (calcd. for
C15H9O5, 269.0455).3,6-Dihydroxy-1-methoxy-9,10-anthraquinone (2): yellow-
ish amorphous solid; UV (MeOH) lmax nm (log e) 216
(4.11), 280 (4.37), 333 (2.63), 411 (2.59); IR (KBr) nmax cm
1
3202, 2847, 1655, 1598, 1574, 1493, 1460, 1347, 1302, 1277,
1211, 1153, 1105, 1037, 981, 938, 888, 844, 793, 750, 732; 1H
NMR (MeOH-d4, 600 MHz) data, see Table 1;
13C NMR
(MeOH-d4, 125 MHz) data, see Table 2; ()–ESI–MS m/z 269
[M–H]; (þ)–HR–ESI–MS m/z 271.0599 [MþH]þ (calcd. for
C15H11O5, 271.0607).
3,5,6-Trihydroxy-2-hydroxymethyl-9,10-anthraquinone (3):
orange amorphous solid; UV (MeOH) lmax nm (log e) 221
(3.93), 277 (4.48), 426 (3.82); IR (KBr) nmax cm
1 3346, 3315,
1651, 1633, 1579, 1496, 1445, 1427, 1311, 1257, 1176, 1111,
1041, 1022, 991, 918, 891, 841, 810, 748, 663; 1H NMR
(DMSO-d6, 500 MHz) data, see Table 1;
13C NMR (DMSO-
d6, 125 MHz) data, see Table 2; ()–HR–ESI–MS m/z
285.0407 [M–H] (calcd. for C15H9O6, 285.0405).
1,3,5,6-Tetrahydroxy-2-ethoxymethyl-9,10-anthraquinone
(4): red orange needles, mp 192 1C; UV (MeOH) lmax nm
(log e) 205 (4.11), 228 (4.38), 274 (4.35), 315 (sh, 3.82), 466
(3.28); IR (KBr) nmax cm
1 3455, 3202, 2975, 2919, 2885, 1646,
1602, 1482, 1453, 1415, 1394, 1331, 1307, 1265, 1221, 1185,
1129, 1093, 1076, 1057, 1006, 995, 953, 888, 834, 818, 787, 754,
714, 655, 598, 545; 1H NMR (DMSO-d6, 500 MHz) data, see
Table 1; 13C NMR (DMSO-d6, 125 MHz) data, see Table 2;
()–HR–ESI–MS m/z 329.0662 [M–H] (calcd. for C17H13O7,
329.0667)
1,3,5-Trihydroxy-6-methoxy-2-methoxymethyl-9,10-anthra-
quinone (5): yellowish amorphous solid; UV (MeOH) lmax nm
(log e) 204 (4.07), 227 (4.38), 265 (4.23), 290 (sh, 4.11), 312 (sh,
3.67), 449 (3.46); IR (KBr) nmax cm
1 3237, 2919, 2850, 1727,
1620, 1593, 1470, 1442, 1414, 1376, 1322, 1255, 1213, 1179,
1141, 1101, 1049, 976, 941, 894, 883, 833, 777, 712, 688, 651,
552; 1H NMR (CDCl3, 500 MHz) data, see Table 1;
13C NMR
(CDCl3, 125 MHz) data, see Table 2; ()–ESI–MS m/z 329
[M–H]; ()–HR–ESI–MS m/z 329.0652 [M–H] (calcd. for
C17H13O7, 329.0667).
1,3,6-Trihydroxy-2-hydroxymethyl-9,10-anthraquinone-3-
hydroxy-2-hydroxymethyl-acetonide (6): yellowish amorphous
solid; UV(MeOH) lmax nm (log e) 203 (3.92), 220 (4.41), 281
(4.82), 344 (2.76), 417 (2.64); IR (KBr) nmax cm
1 3433, 2924,
2855, 1740, 1663, 1628, 1582, 1478, 1401, 1312, 1277, 1236,
1121, 991, 849, 828, 757; 1H NMR (acetone-d6, 500 MHz)
data, see Table 1; 13C NMR (acetone-d6, 125 MHz) data, see
Table 2; ()–ESI–MS m/z 325 [M–H]; ()–HR–ESI–MS m/z
325.0711 [M–H] (calcd. for C18H13O6, 325.0718).
1,3,5-Trihydroxy-2-hydroxymethyl-6-methoxy-9,10-anthra-
quinone-3-hydroxy-2-hydroxymethyl-acetonide (7): red orange
amorphous solid; UV (CHCl3) lmax nm (log e) 271 (3.22), 291
(sh, 3.07), 313 (sh, 2.36), 449 (2.45); IR (KBr) nmax cm
1 3075,
2981, 2921, 2852, 1741, 1674, 1613, 1461, 1429, 1404, 1372,
1324, 1271, 1229, 1204, 1154, 1127, 1109, 1052, 1030, 964, 951,
898, 857, 821, 806, 776, 727, 657; 1H NMR (CDCl3, 500 MHz)
data, see Table 1; 13C NMR (CDCl3, 125 MHz) data, see
Table 2; ()–HR–ESI–MS m/z 355.0812 [M–H] (calcd. for
C19H15O7, 355.0823).
1,3-Dihydroxy-2-hydroxymethyl-9,10-anthraquinone-3-
hydroxy-2-hydroxymethyl-acetonide (8): yellowish amorphous
solid; UV(MeOH) lmax nm (log e) 210 (3.47), 242 (3.77), 275
(3.80), 403 (2.55); IR (KBr) nmax cm
1 3069, 2998, 2923, 2866,
1674, 1629, 1592, 1403, 1304, 1275, 1120, 946, 855, 793, 714;
1H NMR (CDCl3, 500 MHz) data, see Table 1;
13C NMR
Anthraquinones isolated from the ethanol extract of the roots of K. valerianoides 265(CDCl3, 125 MHz) data, see Table 2; ()–HR–ESI–MS m/z
309.0762 [M–H] (calcd. for C18H13O5, 309.0768).
3.5. Etheriﬁcation of compounds 14 and 15
Compounds 14 and 15 (each 5 mg) were dissolved separately
in methanol (5 mL) or ethanol (5 mL). The solutions were
stirred at room temperature for 24 h, then reﬂuxed for another
12 h. Frequent TLC tests [petroleum etheracetone (2:1)] of
the solutions showed that no product was formed at room
temperature, whereas products were generated while the
solutions were reﬂuxed. After reﬂuxed for 12 h, the solutions
were evaporated to dryness, and the residues were separated
by preparative TLC [petroleum etheracetone (2:0.8)]. A sole
product was obtained from each of the residues. The products
(1.6 mg and 1.3 mg, respectively) obtained from the residues of
ethanol solutions of 14 and 15, displayed ESI–MS and 1H
NMR data identical to compounds 9 or 102,12,13, respectively.
Meanwhile, the products (1.0 mg and 0.8 mg, respectively),
obtained from the residues of the methanol solutions, showed
ESI–MS and 1H NMR data completely identical to 11 or
1212–14, respectively.
3.6. Acetonide formation of compounds 14 and 16 and
decomposition of S16
Compounds 14 (4 mg) and 16 (10 mg) were separately sus-
pended in 5 mL of acetone. The suspensions were stirred at
room temperature for 24 h, and then reﬂuxed for 48 h.
Frequent TLC test [petroleum etherethyl acetate (2:0.3)] of
the suspensions showed that no product was generated at
room temperature, whereas products were generated while the
suspensions were reﬂuxed. After reﬂuxing for 48 h, the
suspensions were evaporated to dryness, and the residues were
separated by preparative TLC [petroleum etherethyl acetate
(2:0.3)]. A major product (0.5 mg), displaying ESI–MS and 1H
NMR data completely identical to those of compound 8, was
obtained from the residue of the suspension of 14. From the
residue of the suspension of 16, S16 was obtained as a
yellowish powder and identiﬁed as 3-hydroxy-2-hydroxy-
methyl-1-methoxy-9,10-anthraquinone-3-hydroxy-2-hydroxy-
methyl-acetonide by following spectroscopic data: 1H NMR
(CDCl3, 600 MHz) d 7.44 (1H, s, H-4), 8.23 (1H, d, J¼7.2 Hz,
H-8), 8.19 (1H, d, J¼7.2 Hz, H-5), 7.90 (1H, dd, J¼7.2 and
7.2 Hz, H-7), 7.85 (1H, dd, J¼7.2 and 7.2 Hz, H-6), 4.99 (2H,
s, H2-11), 3.96 (3H, s, CH3O-1), 1.58 (6H, s, CH3-1
0 and CH3-
30); (þ)–ESI–MS m/z 325 [MþH]þ. A solution of compound
S16 (5.1 mg) in CHCl3 (3 mL) and in acetone (3 mL) was each
kept at ambient conditions for two weeks. Each solution was
evaporated to dryness, and the residue was separated by
preparative TLC [petroleum etherethyl acetate (2:0.3)] to
yield S16a (1.5 mg and 0.4 mg respectively from the CHCl3
and acetone solutions) and S16b (1.1 mg and 1.9 mg respec-
tively from the CHCl3 and acetone solutions). The spectro-
scopic data of S16a were in agreement with those of
damacanthal19. S16b was obtained as a yellowish powder
and identiﬁed as 2-carboxyl-3-hydroxy-1-methoxy-9,10-
anthraquinone-2-carboxyl-3-hydroxy-acetonide by following
spectroscopic data: 1H NMR (CDCl3, 600 MHz) d 7.70 (1H,
s, H-4), 8.30 (1H, dd, J¼7.2 and 1.2 Hz, H-8), 8.24 (1H, dd,
J¼7.2 and 1.2 Hz, H-5), 7.84 (1H, ddd, J¼7.8, 7.8 and1.2 Hz, H-7), 7.79 (1H, ddd, J¼7.8, 7.8 and 1.2 Hz, H-6),
4.14 (3H, s, CH3O-1), 1.79 (6H, s, CH3-1
0 and CH3-30).
13C
NMR (CDCl3, 125 MHz): d 181.9 (C-10); 180.3 (C-9); 165.1
(C-11); 160.9, 156.3 (C-1, C-3); 140.7 (C-4a); 135.0 (C-7); 133.6
(C-6); 132.2 (C-8a); 130.9 (C-10a); 127.5 (C-8); 126.9 (C-5);
121.8 (C-2); 112.8 (C-9a); 111.9 (C-4); 106.5 [C-(CH3)2]; 25.7
[C-(CH3)2]. (þ)–ESI–MS m/z 339 [MþH]þ, 361 [MþNa]þ.3.7. HPLC–UV–ESI–MS analysis of K. valerianoides
extracts
Each of 1 g of the pulverised roots of K. valerianoids was
ultrasonicated separately with 20 mL of methanol, ethanol or
acetone for 30 minutes, or reﬂuxed separately with the solvents
for 2 h. After cooling at room temperature, the solution was
ﬁltered, and the ﬁltrate was used as a test solution for HPLC–
UV–ESI–MS analysis [an Alltima (250 mm 2.1 mm i.d.)
column packed with C18 (5 mm); gradient elution of increasing
CH3OH (60–100%) in H2O; elution time: 40 min; ﬂow rate:
1.0 mL/min; detectiton wavelength: 280 nm; ion source tem-
perature: 350 1C; nebuliser (N2): 40 psi; dry gas (N2): 9.0 L/
min; HV Capillary: 3500 V.]3.8. Protective effect on cytotoxicity induced by
DL-galactosamine in WB-F344 Cells18
The hepatoprotective effects were determined by a 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
colorimetric assay in WB-F344 cells, with some modiﬁcation.
Each cell suspension of 1 104 cells in 200 mL of Dulbecco’s
modiﬁed Eagle’s medium (DMEM) containing fetal calf
serum (10%), penicillin (100 units/mL), and streptomycin
(100 mg/mL) was plated in a 96-well microplate and precul-
tured for 24 h at 37 1C under a 5% CO2 atmosphere. After
fresh medium (200 mL) containing bicyclol (the positive con-
trol) or test sample was added, the cells were cultured for 1 h.
Then, the cultured cells were exposed to 50 mM DL-galacto-
samine for 24 h. Cytotoxic effects of test samples were
measured simultaneously in the absence of DL-galactosamine.
The medium was changed into a fresh one containing 0.5 mg/
mL MTT. After 4 h incubation, the medium was removed and
150 mL of DMSO was added to dissolve formazan crystals.
The optical density (OD) of the formazan solution was
measured on a microplate reader at 490 nm. Inhibition (%)
was obtained by the following formula:
inhibition ð%Þ ¼ ½ðODsampleODcontrolÞ=ðODnormal
ODcontrolÞ  100%
The Student’s t-test for unpaired observations between
normal or control and tested samples was carried out to
identify statistical differences; P values less than 0.05 were
considered as signiﬁcantly different.Acknowledgements
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